city New Delhi Usa prevention city New Delhi Usa

Alembic gets USFDA nod for generic ophthalmic solution

Reading now: 488
www.livemint.com

The company has received tentative approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Alcaftadine Ophthalmic Solution, NEW DELHI : Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market Alcaftadine ophthalmic solution, in the American market.

The company has received tentative approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Alcaftadine Ophthalmic Solution, Alembic Pharmaceuticals said in a regulatory filing.

The approved ANDA is therapeutically equivalent to Allergan, Inc's Lastacaft Ophthalmic Solution, 0.25 per cent. The product is indicated for the prevention of itching

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA